Proposed Bill to Protect Genetic Information

<h1>Proposed Bill to Protect Genetic Information</h1> <p>The consultation window is now closed. MOH's page was updated on 8 September 2026, but that update does not itself mean that Parliament has received the Bill, that the proposal was enacted, or that any proposed restriction has commenced. The authoritative status remains consultation-stage policy until a Bill is tabled, passed and brought into force (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, updated 8 September 2026</a>).</p> <p>Singapore's <strong>Ministry of Health (MOH)</strong> is consulting on a proposed Bill to strengthen safeguards for genetic information. The public consultation runs from <strong>7 August 2026, 10am, to 4 September 2026, 6pm</strong>, and MOH says the Bill is expected to be tabled in Parliament in <strong>2027</strong> (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, 7 August 2026</a>). The proposal is not legislation in force; its eventual wording, commencement and parliamentary outcome remain to be determined.</p> <h2>Why MOH is proposing the Bill</h2> <p>Genetic testing can identify a person's predisposition to particular diseases and may support prevention, earlier screening or treatment. MOH says it is establishing national programmes for tests where there are clear gene–disease relationships and proven interventions. The National Familial Hypercholesterolaemia Genetic Testing Programme launched in <strong>June 2025</strong>, and MOH plans to subsidise testing and relevant interventions for <strong>Hereditary Breast and Ovarian Cancer</strong> from <strong>December 2026</strong> (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, 7 August 2026</a>).</p> <p>MOH's stated policy concern is that people may avoid useful testing because they fear genetic results could be used outside healthcare, including in insurance underwriting or employment decisions. The proposed protections are therefore presented as a way to give people confidence to make testing decisions based on health considerations. Subsidy arrangements remain limited to selected programmes, and a genetic result can still be clinically relevant to care.</p> <h2>Proposed protections in insurance and employment</h2> <p>The proposed scope is broader than the selected national testing programmes that MOH names as policy context. It is also narrower than a general claim that every use of genetic information in every setting would be prohibited: the consultation described insurance and employment decisions as the initial non-clinical settings. The public material does not settle the final definitions, exceptions, enforcement mechanism or treatment of every possible use, so those details should not be presented as enacted rules (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, 7 August 2026</a>).</p> <p>The consultation describes rules that would prevent <strong>insurers and employers</strong> from requiring genetic testing, or from requesting or using genetic information in insurance and employment decisions (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, 7 August 2026</a>). MOH says the intended protection would extend beyond genetic information generated under national programmes to <strong>all genetic information</strong>, including information derived from commercially available genetic tests. The consultation describes policy direction, not a final statutory text or a completed list of exceptions, enforcement provisions or commencement dates.</p> <h2>Relationship to the existing insurance moratorium</h2> <p>The proposed Bill would build on the <strong>MOH–Life Insurance Association (LIA) Moratorium on Genetic Testing and Insurance</strong>, introduced in <strong>2021</strong>, which seeks to protect genetic test results from use in insurance underwriting (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, 7 August 2026</a>). The moratorium and the proposed Bill are not interchangeable: the former is the current insurance arrangement described by MOH, while the latter is a proposed statutory framework that would address insurance and employment and would cover genetic information more broadly. The consultation page does not say that the moratorium has been repealed, or that its terms already apply to employment decisions; the proposed Bill's protections are not yet applied to employment decisions. Do not describe the consultation as proof that a new Act has already replaced the moratorium.</p> <h2>Consultation status and interpretation</h2> <p>The consultation window is closed, but closure is not enactment. Feedback submitted by <strong>4 September 2026 at 6pm</strong> will inform MOH's development of the proposed policies, while MOH says the proposed Bill is expected to be tabled in Parliament in 2027 (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, 7 August 2026</a>; <a href="https://www.reach.gov.sg/latest-happenings/public-consultation-pages/2026/public-consultation-on-the-proposed-bill-on-protecting-genetic-information/">REACH, updated 4 September 2026</a>). Until a Bill is enacted and commenced, readers should treat the proposed restrictions as consultation-stage policy, not as a new offence or a current universal prohibition on every use of genetic information.</p> <p>Feedback submitted during the consultation will inform MOH's development of the proposed policies. The consultation closes on <strong>4 September 2026 at 6pm</strong>; MOH's release says the proposed Bill is expected to be tabled in Parliament in 2027 (<a href="https://www.moh.gov.sg/newsroom/public-consultation-on-proposed-bill-to-protect--genetic-information-/">MOH, 7 August 2026</a>). Until a Bill is enacted and commenced, readers should treat the proposed restrictions as consultation-stage policy, not as a new offence or a current universal prohibition on every use of genetic information. The proposal also should not be confused with the separate clinical programmes that expand access to selected genetic testing and interventions.</p>

简介

保护遗传信息的拟议法案

公众咨询期现已结束。卫生部网页于 2026 年九月 8 日更新,但该更新本身并不意味着法案已提交国会、提案已获通过,或任何拟议限制已开始生效。权威状态仍是处于咨询阶段的政策,直至法案提交、通过并生效(卫生部,2026 年九月 8 日更新)。

新加坡卫生部正就一项拟议法案征询意见,以加强对遗传信息的保障。公众咨询期为 2026 年八月 7 日上午 10时至 2026 年九月 4 日下午 6时;卫生部表示,预计于 2027 年将法案提交国会(卫生部,2026 年八月 7 日)。该提案尚未成为生效法律;最终条文、实施日期和国会审议结果仍有待确定。

卫生部提出法案的原因

基因检测可以识别一个人对特定疾病的易感倾向,并有助于预防、提早筛查或治疗。卫生部表示,正在为基因与疾病关系明确且已有经过验证的干预措施的检测项目制定全国计划。家族性高胆固醇血症基因检测计划于 2025 年六月启动;卫生部计划从 2026 年十二月起,为遗传性乳腺癌和卵巢癌相关检测及干预措施提供补贴(卫生部,2026 年八月 7 日)。

卫生部表示,其政策关切在于,人们可能担心基因检测结果会在医疗保健之外被使用,例如用于保险核保或就业决策,因此避开有益的检测。提出这些保障措施,旨在让人们能够基于健康考量,有信心地决定是否接受检测。补贴安排仅适用于特定计划,基因检测结果仍可能与临床护理相关。

保险和就业方面的拟议保障措施

拟议范围比卫生部作为政策背景所提及的特定全国检测计划更广。同时,该提案的范围也没有广泛到禁止在所有情境中使用任何遗传信息:咨询文件将保险和就业决策列为最初拟涵盖的非临床情境。公开资料尚未确定最终定义、例外情况、执行机制或对所有可能用途的处理方式,因此不应将这些细节描述为已生效的规则(卫生部,2026 年八月 7 日)。

咨询文件介绍了拟议规则:禁止保险公司和雇主要求进行基因检测,或在保险和就业决策中索取或使用遗传信息(卫生部,2026 年八月 7 日)。卫生部表示,拟议保障措施将不仅适用于全国计划产生的遗传信息,还将涵盖所有遗传信息,包括从市售基因检测中获取的信息。咨询文件描述的是政策方向,并非最终法条,也未完成例外情况、执法条款或生效日期的清单。

与现行保险暂停安排的关系

拟议法案将在 2021 年推出的卫生部—新加坡人寿保险协会基因检测与保险暂停安排基础上进一步发展;该安排旨在保护基因检测结果不被用于保险核保(卫生部,2026 年八月 7 日)。暂停安排与拟议法案并不能互相替代:前者是卫生部所述的现行保险安排,后者则是拟议的法定框架,涉及保险和就业,并且涵盖范围更广的遗传信息。咨询网页并未表示暂停安排已被废除,也未表示其条款已经适用于就业决策;拟议法案的保障措施目前尚未适用于就业决策。不要将这次咨询描述为新法案已取代暂停安排的证明。

咨询状态和解读

咨询期已经结束,但结束并不等于法案已经通过。卫生部会参考截至 2026 年九月 4 日下午 6时提交的反馈,制定拟议政策;卫生部表示,预计于 2027 年将拟议法案提交国会(卫生部,2026 年八月 7 日;REACH,2026 年九月 4 日更新)。法案通过并生效前,读者应将拟议限制视为咨询阶段的政策,而不是新的刑事罪行或当前对所有遗传信息用途的普遍禁令。

在咨询期间提交的反馈将有助于卫生部制定拟议政策。咨询于 2026 年九月 4 日下午 6时结束;卫生部的公告表示,预计于 2027 年将拟议法案提交国会(卫生部,2026 年八月 7 日)。法案通过并生效前,读者应将拟议限制视为咨询阶段的政策,而不是新的刑事罪行或当前对所有遗传信息用途的普遍禁令。该提案也不应与扩大特定基因检测和干预措施覆盖面的独立临床计划相混淆。